Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 6 June 2027
- Last conf. stmt
- 23 May 2026
Not loaded yet. See them on Companies House
People and entities with significant control, from the Companies House PSC register
Companies where Ingenox Therapeutics Limited is registered as a person with significant control
Balance sheet as at 31 December 2025 · total exemption full accounts
| 2025 | 2024 | |
|---|---|---|
| Fixed Assets | £1,853,556 | £1,580,345 |
| Current Assets | £849,680 | £1,625,232 |
| Debtors | £492,785 | £585,189 |
| Cash | £356,895 | £1,040,043 |
| Creditors (< 1 year) | £10,949,044 | £850,283 |
| Creditors (> 1 year) | £10,949,044 | £7,562,089 |
| Net Current Assets | (£570,465) | £774,949 |
| Net Assets | (£9,665,953) | (£5,206,795) |
| Shareholder Funds | (£9,665,953) | (£5,206,795) |
Filing history not loaded yet. See it on Companies House
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →